NCT07415863 2026-02-17
Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1/2 Recruiting
Clinical Trials
5 trialsNCT05405595 2026-01-07
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Adagene Inc
Phase 1/2 Recruiting
NCT07102004 2025-08-03
Study of MHB088C for Patients With Advanced Solid Malignant Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Recruiting
NCT06922357 2025-05-14
A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors
Shandong Suncadia Medicine Co., Ltd.
Phase 1/2 Recruiting
NCT04645069 2024-08-14
ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors
Adagene Inc
Phase 1/2 Completed